$1.14
+0.09 (+8.57%)
Analyst Consensus
Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+404.4% upside
Low Target
$4.43
Average Target
$5.75
High Target
$6.69
Current Price
$1.14
Current
$1.14
$1.14
Target
$5.75
$5.75
$4.43
$5.75 avg
$6.69
Scenario Analysis
Bear Case
$4.43
288.6%
Low target
Base Case
$5.75
+404.4%
Avg target
Bull Case
$6.69
+486.8%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$6.09
-81.3% from high
52-Week Low
$2.58
+-55.8% from low
Target vs 52W High
$5.75
-5.6% vs high
Next Earnings Report
Mar 2, 2026 · After Market Close
13d
until earnings
EPS Est: $-0.28
Earnings in 13 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |